Simultaneous Delivery of Wharton’s Jelly Mesenchymal Stem Cells and Insulin-Like Growth Factor-1 in Acute Myocardial Infarction
| Author | Shahram Rabbani | en |
| Author | Masoud Soleimani | en |
| Author | Mohammad Sahebjam | en |
| Author | Mohammad Imani | en |
| Author | Azadeh Haeri | en |
| Author | Ali Ghiaseddin | en |
| Author | Seyed Mahdi Nassiri | en |
| Author | Jalil Majd Ardakani | en |
| Author | Maryam Tajik Rostami | en |
| Author | Arash Jalali | en |
| Author | Seyed Hossein Ahmadi Tafti | en |
| Issued Date | 2018-04-30 | en |
| Abstract | Wharton’s jelly mesenchymal stem cells (HWJMSCs) hold promise for myocardial regeneration, but optimal treatment regimen (preferably with a growth factor) is required to maximize functional benefits. The aim of this study was to explore the cardioprotective and angiogenesis effects of HWJMSCs combined with insulin-like growth factor-1 (IGF-1) in the treatment of acute myocardial infarction. | en |
| DOI | https://doi.org/10.22037/ijpr.2018.2203 | en |
| Keyword | Myocardial infarction | en |
| Keyword | Stem cells | en |
| Keyword | IGF-1 | en |
| Keyword | Angiogenesis | en |
| Keyword | Cardiac function. | en |
| Publisher | Brieflands | en |
| Title | Simultaneous Delivery of Wharton’s Jelly Mesenchymal Stem Cells and Insulin-Like Growth Factor-1 in Acute Myocardial Infarction | en |
| Type | Original Article | en |